撤回：lncRNA FOXD3-AS1作为早期肺癌诊断和亚型鉴定生物标志物的评估。
Retracted: Evaluation of lncRNA FOXD3-AS1 as a Biomarker for Early-Stage Lung Cancer Diagnosis and Subtype Identification.
作者信息
And Alternative Medicine Evidence-Based Complementary
出版信息
Evid Based Complement Alternat Med. 2023 Oct 4;2023:9782478. doi: 10.1155/2023/9782478. eCollection 2023.
Abstract
[This retracts the article DOI: 10.1155/2022/5702014.].
摘要
[本文撤回文章DOI: 10.1155/2022/5702014。]
相似文献
1
Retracted: Evaluation of lncRNA FOXD3-AS1 as a Biomarker for Early-Stage Lung Cancer Diagnosis and Subtype Identification.撤回：lncRNA FOXD3-AS1作为早期肺癌诊断和亚型鉴定生物标志物的评估。
Evid Based Complement Alternat Med. 2023 Oct 4;2023:9782478. doi: 10.1155/2023/9782478. eCollection 2023.
2
Evaluation of lncRNA FOXD3-AS1 as a Biomarker for Early-Stage Lung Cancer Diagnosis and Subtype Identification.lncRNA FOXD3-AS1作为早期肺癌诊断和亚型鉴定生物标志物的评估
Evid Based Complement Alternat Med. 2022 Sep 14;2022:5702014. doi: 10.1155/2022/5702014. eCollection 2022.
3
Inhibition of LncRNA FOXD3-AS1 suppresses the aggressive biological behaviors of thyroid cancer via elevating miR-296-5p and inactivating TGF-β1/Smads signaling pathway.长链非编码 RNA FOXD3-AS1 的抑制作用通过上调 miR-296-5p 并抑制 TGF-β1/Smads 信号通路抑制甲状腺癌细胞的侵袭和迁移。
Mol Cell Endocrinol. 2020 Jan 15;500:110634. doi: 10.1016/j.mce.2019.110634. Epub 2019 Oct 31.
4
SP1-induced lncRNA FOXD3-AS1 contributes to tumorigenesis of cervical cancer by modulating the miR-296-5p/HMGA1 pathway.SP1 诱导的长链非编码 RNA FOXD3-AS1 通过调节 miR-296-5p/HMGA1 通路促进宫颈癌的发生。
J Cell Biochem. 2021 Feb;122(2):235-248. doi: 10.1002/jcb.29846. Epub 2020 Sep 22.
5
Exosomal lncRNA FOXD3-AS1 upregulates ELAVL1 expression and activates PI3K/Akt pathway to enhance lung cancer cell proliferation, invasion, and 5-fluorouracil resistance.外泌体 lncRNA FOXD3-AS1 上调 ELAVL1 表达并激活 PI3K/Akt 通路，增强肺癌细胞增殖、侵袭和 5-氟尿嘧啶耐药性。
Acta Biochim Biophys Sin (Shanghai). 2021 Nov 10;53(11):1484-1494. doi: 10.1093/abbs/gmab129.
6
Highly expressed lncRNA FOXD3-AS1 promotes non-small cell lung cancer progression via regulating miR-127-3p/mediator complex subunit 28 axis.高表达长链非编码 RNA FOXD3-AS1 通过调控 miR-127-3p/中介体复合物亚基 28 轴促进非小细胞肺癌进展。
Eur Rev Med Pharmacol Sci. 2020 Mar;24(5):2525-2538. doi: 10.26355/eurrev_202003_20520.
7
lncRNA FOXD3-AS1 promotes the progression of non-small cell lung cancer by regulating the miR-135a-5p/CDK6 axis.长链非编码RNA FOXD3-AS1通过调控miR-135a-5p/CDK6轴促进非小细胞肺癌进展。
Oncol Lett. 2021 Dec;22(6):853. doi: 10.3892/ol.2021.13114. Epub 2021 Oct 26.
8
LncRNA FOXD3-AS1 promotes proliferation, invasion and migration of cutaneous malignant melanoma via regulating miR-325/MAP3K2.长链非编码 RNA FOXD3-AS1 通过调控 miR-325/MAP3K2 促进皮肤恶性黑色素瘤的增殖、侵袭和迁移。
Biomed Pharmacother. 2019 Dec;120:109438. doi: 10.1016/j.biopha.2019.109438. Epub 2019 Sep 18.
9
LncRNA FOXD3-AS1 promotes breast cancer progression by mediating ARF6.长链非编码 RNA FOXD3-AS1 通过介导 ARF6 促进乳腺癌的进展。
Breast Cancer. 2022 Sep;29(5):908-920. doi: 10.1007/s12282-022-01373-x. Epub 2022 Jun 9.
10
Long noncoding RNA FOXD3-AS1 regulates oxidative stress-induced apoptosis sponging microRNA-150.长链非编码RNA FOXD3-AS1通过靶向微小RNA-150调控氧化应激诱导的细胞凋亡
FASEB J. 2017 Oct;31(10):4472-4481. doi: 10.1096/fj.201700091R. Epub 2017 Jun 27.
本文引用的文献
1
Evaluation of lncRNA FOXD3-AS1 as a Biomarker for Early-Stage Lung Cancer Diagnosis and Subtype Identification.lncRNA FOXD3-AS1作为早期肺癌诊断和亚型鉴定生物标志物的评估
Evid Based Complement Alternat Med. 2022 Sep 14;2022:5702014. doi: 10.1155/2022/5702014. eCollection 2022.
Zotero 插件